Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/12/2026

1. ORCL
2. SPY
3. SPCX
4. USO
5. CHWY
6. ADBE
7. NAVN
8. HUMA
9. NVDA
10. CRWV

Go back to Edesa Biotech Reports Phase 2b Study Reaches Full Enrollment
(NASDAQ: EDSA) Delayed: 5.65 --0 (-0%)
Previous Close $5.65    52 Week High $ 
Open $5.65    52 Week Low $ 
Day High $5.65    P/E N/A 
Day Low $5.65    EPS $ 
Volume 2,171